Apo-1/Fas (CD95) Gene Polymorphism in Korean Hepatocellular Carcinoma Patients |
Kim, Sung-Soo
(Department of Pharmacology, College of Medicine, Kangwon National University)
Hong, Seung-Jae (Division of Rheumatology, Department of Internal Medicine, College of Medicine, KyungHee University) Ahn, Yun-Gul (Department of Pharmacology, College of Medicine, Kangwon National University) Kim, Bong-Seog (Department of Pharmacology, College of Medicine, Kangwon National University,Division of Hemato- oncology, Department of Internal Medicine, Seoul Veterans Hospital) Yuh, Young-Jin (Department of Pharmacology, College of Medicine, Kangwon National University,Department of Internal Medicine, Sanggye Paik Hospital, College of Medicine, Inje University) Han, Kye-Young (Department of Orthopaedic Surgery, College of Medicine, Kangwon National University) Lee, Hee-Jae (Kohwang Medical Research Institute, College of Medicine, Kyung Hee University) Chung, Joo-Ho (Kohwang Medical Research Institute, College of Medicine, Kyung Hee University) Yim, Sung-Vin (Department of Pharmacology, College of Medicine, Kangwon National University) Cho, Jae-Young (Department of Anatomy, College of Medicine, Seoul National University) Park, Yeon-Hee (Division of Medical Oncology, Korea Cancer Center Hospital) |
1 | Alameddine FM, Zafari AM. Genetic polymorphisms and oxidative stress in heart failure. Congest Heart Fail 8: 157-164, 2002 DOI ScienceOn |
2 | Farker K, Schotte U, Scheele J, Hoffmann A. Assessment of frequencies of lifestyle factors and polymorphisms of drugmetabolizing enzymes (NAT2, CYP2E1) in human hepatocellular carcinoma (HCC) patients in a department of surgical medicine-a pilot investigation. Int J Clin Pharmacol Ther 40: 120-124, 2002 DOI |
3 | Huang QR, Danis V, Lassere M, Edmonds J, Manolios N. Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients. Rheumatology (Oxford) 38: 645-651, 1999 DOI ScienceOn |
4 | Huang QR, Teutsch SM, Buhler MM, Bennetts BH, Heard RN, Manolios N, Stewart GJ. Evaluation of the apo-1/Fas promoter mva I polymorphism in multiple sclerosis. Mult Scler 6: 14-18, 2000 DOI |
5 | Lee YH, Ji JD, Sohn J, Song GG. Polymorphsims of CTLA-4 exon 1 +49, CTLA-4 promoter -318 and Fas promoter -670 in spondyloarthropathies. Clin Rheumatol 20: 420-422, 2001 DOI ScienceOn |
6 | Rogler CE, Chisari FV. Cellular and molecular mechanisms of hepatocarcinogenesis. Semin Liver Dis 12: 265-278, 1992 DOI ScienceOn |
7 | Yu MW, Chiu YH, Yang SY, Santella RM, Chern HD, Liaw YF, Chen CJ. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers. Br J Cancer 80: 598-603, 1999 DOI ScienceOn |
8 | Yu MW, Pai CI, Yang SY, Hsiao TJ, Chang HC, Lin SM, Liaw YF, Chen PJ, Chen CJ. Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk. Gut 47: 703-709, 2000 DOI ScienceOn |
9 | Kim SA, Kim YJ, Choe BK, Lee HJ, Kim JW, Park JD, Kim CJ, Park SJ, Jung JC, Chung JH. Assessment of an Apo-1/Fas promoter polymorphism in Korean schizophrenia patients. Korean J Physiol Pharmacol 6: 131-138, 2002 |
10 | Maeda T, Kamihira S. Apoptosis, Part II: The role of mutated Fas genes in tumorigenesis. Adv Clin Chem 36: 109-137, 2001 DOI PUBMED |
11 | Nagata S. Fas ligand-induced apoptosis. Annu Rev Genet 33: 29- 55, 1999 DOI PUBMED ScienceOn |
12 | Huang QR, Morris D, Manolios N. Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene. Mol Immunol 34: 577-582, 1997 DOI ScienceOn |
13 | Lee SH, Shin MS, Lee HS, Bae JH, Lee HK, Kim HS, Kim SY, Jang JJ, Joo M, Kang YK, Park WS, Park JY, Oh RR, Han SY, Lee JH, Kim SH, Lee JY, Yoo NJ. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma. Hum Pathol 32: 250-256, 2001 DOI ScienceOn |
14 | Monto A, Wright TL. The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol 28: 441-449, 2001 DOI ScienceOn |
15 | Zhang YJ, Chen SY, Chen CJ, Santella RM. Polymorphisms in cyclin D1 gene and hepatocellular carcinoma. Mol Carcinog 33: 125-129, 2002 DOI ScienceOn |
16 | Schmitz I, Kirchhoff S, Krammer PH. Regulation of death receptormediated apoptosis pathways. Int J Biochem Cell Biol 32: 1123-1136, 2000 DOI ScienceOn |
17 | Thorgeirsson SS, Teramoto T, Factor VM. Dysregulation of apoptosis in hepatocellular carcinoma. Semin Liver Dis 18: 115- 122, 1998 DOI ScienceOn |
18 | Tiemersma EW, Omer RE, Bunschoten A, van't Veer P, Kok FJ, Idris MO, Kadaru AM, Fedail SS, Kampman E. Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 10: 785-791, 2001 |
19 | Müllauer L, Gruber P, Sebinger D, Buch J, Wohlfart S, Chott A. Mutations in apoptosis genes: a pathogenetic factor for human disease. Mutat Res 488: 211-231, 2001 DOI ScienceOn |
20 | Sud R, Wells D, Talbot IC, Delhanty JD. Genetic alterations in gastric cancers from British patients. Cancer Genet Cytogenet 126: 111-119, 2001 DOI ScienceOn |
21 | Montesano R, Hall J. Environmental causes of human cancers. Eur J Cancer 37: S67-S87, 2001 |
22 | Fan XQ, Guo YJ. Apoptosis in oncoloy. Cell Res 11: 1-7, 2001 DOI ScienceOn |
23 | Sharma K, Wang RX, Zhang LY, Yin DL, Luo XY, Solomon JC, Jiang RF, Markos K, Davidson W, Scott DW, Shi YF. Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacol Ther 88: 333-347, 2000 DOI ScienceOn |
24 | Peter ME, Krammer PH. Mechanisms of CD95 (APO-1/Fas)- mediated apoptosis. Curr Opin Immunol 10: 545-551, 1998 DOI ScienceOn |